The next generation of immunotherapies for lung cancers Summary Next-generation lung cancer immunotherapies are expanding beyond traditional checkpoint inhibitors like PD-1/PD-L1 antibodies. Scientists are exploring novel targets and approaches to overcome resistance and improve Read More